
Sign up to save your podcasts
Or


This episode examines how Social Information Processing mechanisms shape reactive and proactive aggressive behavior in adults, detailing the specific cognitive processes that distinguish impulsive retaliation from calculated, goal-oriented actions. The discussion breaks down each stage of social cognitive processing, explaining how early cue interpretations—such as hostile attribution bias—uniquely fuel reactive responses triggered by perceived threat or frustration. Conversely, latter decision-making stages, including positive result expectations and perceived self-efficacy, drive both reactive and proactive aggressive behaviors by reinforcing the belief that aggression yields desirable outcomes or is easy to execute. Additionally, the episode highlights key sex differences, uncovering how cognitive evaluations, outcome expectations, and perceived self-efficacy operate differently between men and women across reactive and proactive contexts.
In 2026, developing Asia and the Pacific faces a complex economic landscape shaped by energy market disruptions, persistent inflation, and shifting global trade policies. Prolonged geopolitical conflicts have driven up commodity and shipping costs, placing fiscal pressure on governments and influencing central bank interest rate decisions across the region. Despite these macroeconomic headwinds, economic growth remains supported by resilient domestic demand, high-tech manufacturing, and an expanding artificial intelligence investment cycle. Simultaneously, targeted social policies and poverty alleviation programs across the region are proving to deliver significant human capital benefits, enhancing health outcomes, educational expenditures, and adult cognitive function. This episode explores the critical interplay between global market volatility, regional trade dynamics, and national social programs driving economic trajectory.
Researchers at Harvard University and the Broad Institute have sustained human brain organoids in laboratory cultures for over five years, establishing a record for long-term 3D human neural tissue growth. Published in Nature, the study shows that these stem-cell-derived cerebral cortex models continue to mature, following predictable molecular, epigenomic, and electrical developmental sequences that parallel human brain maturation from gestation into early postnatal life. By optimizing the culture medium to maintain spontaneous neuronal firing and supplementing energy sources, the team preserved fragile neurons alongside supporting astrocytes across extended timescales. Notably, experiments combining cells of different developmental ages revealed an intrinsic cellular clock: older neural progenitors retained a memory of their developmental history and jumped ahead to generate late-stage neurons when prompted. This five-year milestone provides a durable, reproducible platform to investigate long-term human neurodevelopment and study conditions such as autism, schizophrenia, and neurodegenerative disorders.
Cardiovascular disease remains the leading cause of death globally, but new findings show that its underlying driver, silent atherosclerosis, begins decades before symptoms appear. The REACT study imaged over 16,000 asymptomatic adults aged 18 to 70 in Denmark and Spain, revealing that 57.1% had detectable arterial plaque despite no prior diagnosis or symptoms. Alarmingly, the disease was present in roughly one in thirteen young adults aged 18 to 29, rising progressively to nine out of ten individuals by ages 60 to 70. The research highlights critical sex differences: men show earlier plaque development, running five to ten years ahead of women, while women experience a sharp acceleration in plaque burden during the menopausal transition. Importantly, standard cardiovascular risk calculators like SCORE2 failed to identify a significant majority of individuals with early plaque, particularly among younger populations. Because most individuals with coronary plaque also exhibit disease in peripheral vessels like the carotid or femoral arteries, accessible non-invasive imaging tools such as portable ultrasound offer a practical path toward early screening. Shifting from indirect risk estimations to direct vascular imaging allows clinicians to detect subclinical disease early and tailor personalized preventive strategies before major cardiac events occur.
Recent medical advances are transforming our understanding of complex diseases, ranging from targeted cancer therapies to the cellular mechanisms of depression, artificial intelligence in healthcare, sleep science, and genetic disorders. In oncology, the FDA-approved oral drug daraxonrasib has established a new standard of care for advanced pancreatic cancer by acting as a RAS(ON) inhibitor that blocks signals driving tumor growth, nearly doubling median overall survival compared to standard chemotherapy in landmark phase 3 clinical trials. In neuroscience, single-cell resolution mapping of nearly half a million hippocampal brain cells has revealed that major depressive disorder is characterized by stalled adult neurogenesis and disrupted neural circuit adaptability, shifting the scientific paradigm away from simple neurotransmitter imbalances toward structural and circuit-level resilience. Meanwhile, clinical integration of artificial intelligence through early warning systems like CONCERN uses nurses' electronic documentation patterns to detect patient deterioration up to two days earlier, significantly reducing mortality risks and hospital stay durations. In sleep research, organ-specific biological aging clocks demonstrate a clear U-shaped relationship where both short and long sleep accelerate systemic aging across major organ systems, identifying an optimal sleep window between 6.4 and 7.8 hours daily. Finally, pioneering research into epigenetic regulation and the MeCP2 protein has demonstrated that severe neurodevelopmental conditions such as Rett syndrome can be reversed, inspiring novel gene and RNA therapies currently advancing through clinical trials.
Recent findings from the CALERIE trial reveal that moderate calorie restriction of 11 to 14 percent over two years significantly lowers levels of complement component 3, an immune system protein that drives chronic age-related inflammation. Researchers discovered that the age-related rise in this protein stems primarily from specialized macrophages in visceral fat tissue rather than the liver. Remarkably, the drop in complement component 3 occurs independently of total weight loss, demonstrating a specific metabolic effect on adipose tissue biology. Preclinical studies show that directly inhibiting this immune pathway reduces inflammaging in animal models, offering a promising target for therapies that could replicate the longevity benefits of dietary restriction without strict caloric limits. Additionally, broader investigations using epigenetic clocks confirm that targeted lifestyle interventions and select metabolic medications can measurably slow biological aging, whereas standard over-the-counter supplements show negligible effects.
Scientific research on habitual coffee consumption reveals intriguing links between daily coffee intake, internal body composition, and endocrine markers. In a large population study of adults examined at age 46, individuals consuming higher amounts of coffee demonstrated lower total and visceral fat mass alongside greater skeletal muscle mass compared to lighter drinkers, despite maintaining virtually identical Body Mass Index levels and waist circumferences. Across both men and women, heavier coffee intake correlated with lower circulating levels of branched-chain amino acids, a key metabolic biomarker linked to insulin sensitivity. Furthermore, male coffee drinkers exhibited a distinct hormonal pattern characterized by higher total and bioavailable testosterone as well as elevated sex hormone-binding globulin, paired with modestly lower free testosterone. Women showed a milder hormonal profile featuring increased sex hormone-binding globulin and reduced free androgens. Although these observational findings reflect population-level correlations rather than direct cause-and-effect proof, they illustrate how coffee's complex array of bioactive compounds interacts with metabolic and hormonal pathways beneath scale-weight measurements.
This episode examines scientific discussions surrounding whether amyloid-beta pathology, a key protein feature in cerebral amyloid angiopathy and Alzheimer's disease, could theoretically be transmitted through blood transfusions. While historical medical procedures involving cadaver-derived pituitary growth hormone and dura mater grafts showed rare instances of iatrogenic amyloid-beta transmission, these practices were discontinued decades ago. Recent epidemiological analyses from Scandinavian health registries identified an association where recipients of blood from donors who later suffered multiple brain hemorrhages faced an elevated risk of subsequent brain bleeds, pointing toward a possible transmissible vascular factor. However, leading researchers emphasize that this observational signal does not prove direct causation or demonstrate that Alzheimer's disease or dementia can be acquired through modern blood products. Large observational studies show no increased risk of Alzheimer's disease among transfusion recipients, and medical experts stress that life-saving blood transfusions remain safe and essential while precautionary research continues.
Astrocytes play a crucial role in integrating neuromodulatory signals from the locus coeruleus to regulate vigilance, memory, and behavioral states. When noradrenaline is released during acute startle or heightened arousal, it binds to astrocytic alpha-1 adrenergic receptors to trigger rapid cytosolic calcium surges. During prolonged periods of vigilance, sustained noradrenergic activity engages beta-adrenergic receptors, elevating cyclic AMP levels over longer timeframes to drive glycogenolysis, supply energy, and support memory consolidation. However, acute exposure to ethanol disrupts this pathway by inhibiting noradrenaline release from locus coeruleus terminals, effectively abolishing vigilance-dependent astroglial network activation and impairing attention. Meanwhile, substances like ketamine hyperactivate the noradrenergic-astroglial circuit, inducing neural plasticity and long-term behavioral perseverance. In neurodegenerative conditions such as Alzheimer's disease, deficits in noradrenergic transmission disrupt astrocytic calcium signaling, underscoring the fundamental role of astroglial-neuromodulatory interactions in cognitive function and brain health.
Warren Sturgis McCulloch was a pioneering neurophysiologist and cyberneticist who sought to map the physical and logical foundations of human thought. Combining a background in philosophy, psychology, mathematics, and medicine, McCulloch investigated how neural circuitry processes information and computes ideas. In 1943, together with Walter Pitts, he published the seminal paper proposing formal threshold neurons, demonstrating that networks of biological neurons could perform logical operations equivalent to a Turing machine and laying the foundation for artificial neural networks. McCulloch served as a central organizer and chairman of the Macy Conferences on Cybernetics, collaborating with key figures like Norbert Wiener, John von Neumann, and Margaret Mead to establish an interdisciplinary science of feedback mechanisms, information theory, and self-organizing systems. His research spanned experimental epistemology, the function of the reticular formation, sensory processing in the visual system, and theoretical frameworks for ethical and autonomous artifacts.
From the publisher's feed